Smithfield Foods could be one of the year's biggest U.S. initial public offerings, with the pork producer planning to raise ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

The Inner Mongolia-based maker of carbonated beverages, juices and protein drinks is working with advisers on the size and ...

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...

Seven IPOs and one SPAC priced this past week, as more sizable issuers filed to go public in the US. Read more here.

EcoCeres Inc., a producer of sustainable fuel backed by Bain Capital, is exploring an initial public offering that could ...

Shares of Ascentage Pharma Group International pared earlier losses to rise 0.75% in the Chinese biopharmaceutical company’s ...

Phoenix Asia Holdings faces significant risks, including regulatory risks, customer concentration and uncertainties in the ...

Ascentage is looking to use the IPO proceeds to advance its Phase III candidates for chronic or small lymphocytic leukemia ...

Chinese banks have been pitching to work on the blockbuster Hong Kong secondary listing of the world’s leading EV battery maker CATL for as little as 0.01 per cent in fees, highlighting cut-throat ...

A global biopharma with a U.S. headquarters in Montgomery County is gearing up to go public on a U.S. exchange.

CHINESE soda maker Dayao is gearing up for a Hong Kong initial public offering (IPO) as early as the second half of 2025, ...